1) Mukai M, et al.:Mechanism and management of cancer-associated thrombosis. J Cardiol 2018;72:89-93.
2) Navi BB, et al.:Ischemic stroke in cancer patients:A review of an underappreciated pathology. Ann Neurol 2018;83:873-883.
3) Lee D, et al.:Intra-arterial thrombectomy for acute ischaemic stroke patients with active cancer. J Neurol 2019;266:2286-2293.
4) Sallustio F, et al.:Safety and Efficacy of Reperfusion Therapies for Acute Ischemic Stroke Patients with Active Malignancy. J Stroke Cerebrovasc Dis 2019;28:2287-2291.
5) Cho BH, et al.:Outcomes of endovascular treatment in acute ischemic stroke patients with current malignancy. Neurol Sci 2020;41:379-385.
6) Ozaki T, et al.:Endovascular Therapy of Acute Ischemic Stroke in Patients with Large-Vessel Occlusion Associated with Active Malignancy. J Stroke Cerebrovasc Dis 2021;30:105455.
7) Yoo J, et al.:Immediate and Long-Term Outcomes of Reperfusion Therapy in Patients With Cancer. Stroke 2021 Apr 29;STROKEAHA120032380. doi:10.1161/STROKEAHA.120.032380.
8) Jung S, et al.:Procedural and clinical outcomes of endovascular recanalization therapy in patients with cancer-related stroke. Interv Neuroradiol 2018;24:520-528.
9) Ciolli L, et al.:Efficacy of mechanical thrombectomy in patients with ischemic stroke and cancer. J Clin Neurosci 2021;91:20-22.
10) Lee EJ, et al.:Effectiveness of mechanical thrombectomy in cancer-related stroke and associated factors with unfavorable outcome. BMC Neurol 2021;21:57.
11) 塩澤真之, 他:脳循環障害の画像診断 末期癌に合併した急性期脳梗塞に対し血栓回収療法を施行した1例. 脳と循環 2017;22:57-63.
12) Kuroda N, et al.:Mechanical Thrombectomy for Trousseau Syndrome in a Terminally Ill Cancer Patient. J Pain Symptom Manage 2019;57:688-694.
13) Park H, et al.:Histological features of intracranial thrombi in stroke patients with cancer. Ann Neurol 2019;86:143-149.
14) Fu CH, et al.:Fibrin and platelet-rich composition in retrieved thrombi hallmarks stroke with active cancer. Stroke 2020;51:3723-3727.
15) Hashimoto T, et al.:Histopathologic Analysis of Retrieved Thrombi Associated With Successful Reperfusion After Acute Stroke Thrombectomy. Stroke 2016;47:3035-3037.
16) Maekawa K, et al.:Erythrocyte-rich thrombus is associated with reduced number of maneuvers and procedure time in patients with acute ischemic stroke undergoing mechanical thrombectomy. Cerebrovasc Dis Extra 2018;8:39-49.
17) Shin JW, et al.:High red blood cell composition in clots is associated with successful recanalization during intra-arterial thrombectomy. PLoS One 2018;13:e0197492.
18) Gunning GM, et al.:Clot friction variation with fibrin content;implications for resistance to thrombectomy. J Neurointerv Surg 2018;10:34-38.
19) Boodt N, et al.:Mechanical Characterization of Thrombi Retrieved With Endovascular Thrombectomy in Patients With Acute Ischemic Stroke. Stroke 2021;52:2510-2517.
20) Jeon Y, et al.:Mechanical thrombectomy in patients with acute cancer-related stroke:is the stent retriever alone effective? J Neurointerv Surg 2021;13:318-323.
21) 秋本大輔, 他:非細菌性血栓性心内膜炎による脳主幹動脈閉塞に対する治療戦略. 脳神経外科速報 2021;31:813-817.
22) Liebeskind DS, et al.:CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke 2011;42:1237-1243.
23) Brinjikji W, et al.:Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome:A systematic review. J Neurointerv Surg 2017;9:529-534.
24) Fitzgerald ST, et al.:Platelet-rich clots as identified by Martius Scarlet Blue staining are isodense on NCCT. J Neurointerv Surg 2019;11:1145-1149.
25) Nouh AM, et al.:Three territory sign:An MRI marker of malignancy-related ischemic stroke(Trousseau syndrome). Neurol Clin Pract 2019;9:124-128.
26) Donati MB:Cancer and thrombosis:from Phlegmasia alba dolens to transgenic mice. Thromb Haemost 1995;74:278-81.
27) Key NS, et al.:Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer:ASCO Clinical Practice Guideline Update. J Clin Oncol 2020;38:496-520.
28) Varki A:Trousseau's syndrome:multiple definitions and multiple mechanisms. Blood 2007;110:1723-1729.
29) Yamaura G, et al.:Therapeutic efficacy of heparin and direct factor Xa inhibitors in cancer-associated cryptogenic ischemic stroke with venous thromboembolism. Thromb Res 2021;206:99-103.